FDA Approves Ryzumvi Eye Drops for Presbyopia

by Medscape • 2026/10/19 • 0 Comments

The medication is currently approved to treat pharmacologically induced mydriasis, or pupil dilation, in adults and children ages 3 years or older.
Medscape Medical News

← How do you set yourself up for ergonomic success?

Perfect Corp. Launches GenAI-Powered Glasses Removal, Letting Glasses Wearers Try On New Frames Without Taking Theirs Off →

Post navigation